Recent changes in breast cancer incidence in Spain, 1980-2004

Journal of the National Cancer Institute

Volumn 101, Issue 22, 2009, Pages 1584-1591

  Pollán, Marina ^a,b   Pastor Barriuso, Roberto ^a,b   Ardanaz, Eva ^a,b,c   Argüelles, Marcial ^d   Martos, Carmen ^c   Galcerán, Jaume ^f   Sánchez Pérez, María José ^b,g   Chirlaque, María Dolores ^b,h   Larrañaga, Nerea ^b,f   Martínez Cobo, Ruth ^f   Tobalina, María Cres ^f   Vidal, Enrique ^e   Marcos Gragera, Rafael ⁱ   Mateos, Antonio ^f   Garau, Isabel ^f   Rojas Martín, María Dolores ^c,j   Jiménez, Rosario ^f   Torrella Ramos, Ana ^f   Perucha, Josefina ^k   Pérez De Rada, Maria Eugenia ^b   González, Susana ^d   Rabanaque, María José ^l   Borrs, Joan ^f   Navarro, Carmen ^b,h   Hernández, Esther ^m   Izquierdo, Ángel ⁱ   López Abente, Gonzalo ^a,b   Martínez, Carmen ^b,g   more..

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^d Direccion General de Salud Publica   (Spain)

^e INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^f Fundació Lliga per A la Investigació i Prevenció Del Càncer ^*  (Spain)

^g ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^h Departamento de Epidemiología   (Spain)

ⁱ Subdireccio General de Vigilancia I Resposta a Emergencies de Salut Publica   (Spain)

^j Dirección General de Salud Pública Y Participación   (Spain)

^k Servicio de Epidemiologia y Prevencion Sanitaria   (Spain)

^l UNIVERSITY OF ZARAGOZA   (Spain)

^m Departamento de Salud Pública de Bizkaia   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER SCREENING; FEMALE; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SPAIN;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; REGISTRIES; SPAIN; TIME FACTORS;

EID: 73049090137     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp358     Document Type: Article

References (47)

1. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Vol 1-8. Lyon, France: IARC; 2005.
2. Parkin DM, Fernandez LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006 ; 12 (suppl 1): S70-S80.
3. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003 ; 39 (12): 1718-1729.
4. Bosch X. Investigating the reasons for Spain's falling birth rate. Lancet. 1998 ; 352 (9131): 887.
5. Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno-Esteban B. Prevalence of obesity in Spain. Med Clin (Barc). 2005 ; 125 (12): 460-466.
6. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2002 ; 5 (6B): 1147-1162.
7. Ministerio de Sanidad y Consumo. Indicadores de Salud 2005. La Salud de la Población Española en el contexto europeo y del SNS. http://www.msc.es/estadEstudios/estadisticas/inforRecopilaciones/ indicadoresSalud.htm. Accessed February 1, 2009.
8. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007 ; 356 (16): 1670-1674.
9. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007 ; 99 (17): 1335-1339. (Pubitemid 47394172)
10. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007; 9 (3): R28.
11. Glass AG, Lacey JV Jr., Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007 ; 99 (15): 1152-1161.
12. Kliewer EV, Demers AA, Nugent ZJ. A decline in breast-cancer incidence. N Engl J Med. 2007 ; 357 (5): 509-510.
13. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2008 ; 107 (3): 427-430.
14. Canfell K, Banks E, Moa AM, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust. 2008 ; 188 (11): 641-644.
15. Johnston M. Breast cancer drop linked to fall in use of HRT. New Zealand Herald. 2006 ; December 20.
16. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet. 2008 ; 372 (9639): 608-610.
17. Allemand H, Seradour B, Weill A, Ricordeau P. Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer. 2008; 95 (1): 11-15.
18. Ponti A, Rosso S, Zanetti R, Ricceri F, Tomatis M, Segnan N. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007 ; 99 (23): 1817-1818.
19. World Health Organization. International Statistical Classifi cation of Diseases and Related Health Problems, Ninth Revision - ICD-9. Geneva, Switzerland: World Health Organization ; 1977.
20. World Health Organization. International Statistical Classifi cation of Diseases and Related Health Problems, Tenth Revision - ICD-10. 2nd ed. Geneva, Switzerland: World Health Organization ; 2004.
21. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents. Vol IX: Lyon, France: IARC ; 2007.
22. McCullagh P, Nelder JA. Generalized Linear Models. London, UK: Chapman and Hall ; 1989.
23. Worsley KJ. An improved Bonferroni inequality and applications. Biometrika. 1982 ; 69 (2): 297-302.
24. Pastor-Barriuso R, Guallar E, Coresh J. Transition models for change-point estimation in logistic regression. Stat Med. 2003 ; 22 (7): 1141-1162.
25. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for join-point regression with applications to cancer rates. Stat Med. 2000 ; 19 (3): 335-351.
26. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002 ; 288 (3): 321-333.
27. Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev. 2007 ; 16 (12): 2773-2780.
28. MacMahon B, Cole P. Is the incidence of breast cancer declining? Epidemiology. 2008 ; 19 (2): 268-269.
29. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003 ; 362 (9382): 419-427.
30. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009 ; 360 (6): 573-587.
31. Lundberg V, Tolonen H, Stegmayr B, Kuulasmaa K, Asplund K. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas. 2004 ; 48 (1): 39-49.
32. Soerjomataram I, Coebergh JW, Louwman MW, Visser O, van Leeuwen FE. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? J Clin Oncol. 2007 ; 25 (31): 5038-5039.
33. Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL. Impressive time-related infl uence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer. 2008 ; 123 (8): 1929-1934.
34. Schneider HP. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med. 1997 ; 42 (suppl 2): 365-375.
35. Benet RM, Carvajal Garcia-Pando A, Garcia DP, Alvarez RA, Vega AT. Hormonal replacement therapy in Spain. Med Clin (Barc). 2002 ; 119 (1): 4-8.
36. Ministerio de Sanidad y Consumo. I.N.E. Encuesta Nacional de Salud de España 2006. Madrid, Spain: Ministerio de Sanidad y Consumo 2007.
37. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed. Luxembourg: Offi ce for Offi cial Publications of the European Communities ; 2006.
38. Ascunce N, Ederra M, Barcos A, Zubizarreta R, Fernández AB, Casamitjana M. Situación del cribado de cáncer de mama en España: características y principales resultados de los programas existentes. In: Castells X, Sala M, Ascunce N, Salas D, Zubizarreta R, Casamitjana M, eds. Descripción del cribado del cáncer en España. Proyecto DESCRIC. Madrid, Spain: Ministerio de Sanidad y Consumo, Agència d'Avaluació de Tecnologia i Recerca Mèdiques de Cataluña ; 2007: 31-73.
39. Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983 ; 118 (6): 865-886.
40. Hery C, Ferlay J, Boniol M, Autier P. Quantifi cation of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol. 2008 ; 19 (6): 1187-1194. (Pubitemid 351796346)
41. Levi F, Te VC, Maspoli M, Randimbison L, Bulliard JL, La Vecchia C. Trends in breast cancer incidence among women under the age of forty. Br J Cancer. 2007 ; 97 (7): 1013-1014.
42. Arroyo A. Fecundidad. In: Arroyo A, eds. Tendencias demográfi cas durante el siglo XX en España. Madrid, Spain: Instituto Nacional de Estadistica ; 2004: 119-162.
43. Soerjomataram I, Pukkala E, Brenner H, Coebergh JW. On the avoid-ability of breast cancer in industrialized societies: older mean age at fi rst birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat. 2008 ; 111 (2): 297-302.
44. Anderson WF, Matsuno RK, Sherman ME, et al. Estimating age-specifi c breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control. 2007 ; 18 (4): 439-447.
45. Onland-Moret NC, Peeters PH, van Gils CH, et al. Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol. 2005 ; 162 (7): 623-632.
46. Anderson WF, Chen BE, Brinton LA, Devesa SS. Qualitative age interactions (or effect modifi cation) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control. 2007 ; 18 (10): 1187-1198.
47. Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defi nes a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008 ; 26 (20): 3324-3330